Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nucleoporin 107 is a prognostic biomarker in hepatocellular carcinoma associated with immune infiltration. | Cancer Med | 2023 | 36952458 | PubTator, text mining | PubMed |
| Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma. | BMC Cancer | 2023 | 36949462 | PubTator, text mining | PubMed |
| Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment. | Cancer Biomark | 2023 | 36938723 | PubTator, text mining | PubMed |
| Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma. | Front Immunol | 2023 | 36936971 | PubTator, text mining | PubMed |
| Emerging roles of astrocytes in blood-brain barrier disruption upon amyloid-beta insults in Alzheimer's disease. | Neural Regen Res | 2023 | 36926705 | PubTator, text mining | PubMed |
| α1-adrenoceptor ligands inhibit chemokine receptor heteromerization partners of α1B/D-adrenoceptors via interference with heteromer formation. | Pharmacol Res | 2023 | 36925091 | PubTator, text mining | PubMed |
| Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer. | Front Immunol | 2023 | 36923407 | PubTator, text mining | PubMed |
| Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID. | Eur Respir J | 2023 | 36922030 | PubTator, text mining | PubMed |
| Comprehensive analysis of the biological function and immune infiltration of SLC38A2 in gastric cancer. | BMC Gastroenterol | 2023 | 36918802 | PubTator, text mining | PubMed |
| Highly purified and functionally stable in vitro expanded allospecific Tr1 cells expressing immunosuppressive graft-homing receptors as new candidates for cell therapy in solid organ transplantation. | Front Immunol | 2023 | 36911743 | PubTator, text mining | PubMed |
| CTHRC1 is associated with immune cell infiltration and functions as an adverse marker for prognosis in head and neck squamous cell carcinoma. | Oncol Lett | 2023 | 36909370 | PubTator, text mining | PubMed |
| Overexpression of Potential Markers of Regulatory and Exhausted CD8+ T Cells in the Peripheral Blood Mononuclear Cells of Patients with B-Acute Lymphoblastic Leukemia. | Int J Mol Sci | 2023 | 36901957 | PubTator, text mining | PubMed |
| Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | 36901700 | PubTator, text mining | PubMed |
| Multi-omics and experimental analysis unveil theragnostic value and immunological roles of inner membrane mitochondrial protein (IMMT) in breast cancer. | J Transl Med | 2023 | 36899366 | PubTator, text mining | PubMed |
| Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3. | J Gynecol Oncol | 2023 | 36890294 | PubTator, text mining | PubMed |
| Role of chemokine-like factor 1 as an inflammatory marker in diseases. | Front Immunol | 2023 | 36865551 | PubTator, text mining | PubMed |
| Studies on the role of non-coding RNAs in controlling the activity of T cells in asthma. | Noncoding RNA Res | 2023 | 36865391 | PubTator, text mining | PubMed |
| Identification of GNG7 as a novel biomarker and potential therapeutic target for gastric cancer via bioinformatic analysis and in vitro experiments. | Aging (Albany NY) | 2023 | 36863706 | PubTator, text mining | PubMed |
| Identification of STAT5B as a biomarker associated with prognosis and immune infiltration in breast cancer. | Medicine (Baltimore) | 2023 | 36862902 | PubTator, text mining | PubMed |
| TOMM34 serves as a candidate therapeutic target associated with immune cell infiltration in colon cancer. | Front Oncol | 2023 | 36845719 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=18